The Value of Multiparametric MRI in Active Surveillance of Prostate Cancer

Transrectal ultrasound guided biopsy (TRUS biopsy) can lead to inaccurate Gleeson scores, under scoring Gleeson values, in 30-40% of prostate cancer cases. Multiparametric MRI guided biopsy advantages over transrectal ultrasound guided biopsy (TRUS Biopsy) include:
- Lower risk of pain and infection.
- Find more clinically significant cancers.
- Find fewer clinically insignificant cancers.
- Reduce the total number of biopsies required.